News ProstaLund AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 17:00:00 10/06/2024 BST			5-day change	1st Jan Change
0.57 ^SEK	+3.64%		-11.76%	-65.03%

05-31	ProstaLund Secures Order for CoreTherm System in Austria	MT
05-16	ProstaLund AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

ProstaLund Secures Order for CoreTherm System in Austria	05-31	MT
New agreement - MR Prof. Dr Karl Diehl starts up with CoreTherm® treatments in Austria	05-31	AQ
ProstaLund AB - Interim report January-March 2024	05-16	AQ
ProstaLund AB Reports Earnings Results for the First Quarter Ended March 31, 2024	05-16	CI
ProstaLund hosted unannounced audit by TÜV SÜD	04-12	AQ
Two new studies with ProstaLund´s Schelin Catheter® presented at EAU24 in Paris	04-08	AQ
ProstaLund AB Presents Two New Studies with Schelin Catheter	04-08	CI
Schelin Catheter® - new study confirms efficiency and ease of use	02-27	AQ
Year-end report – ProstaLund AB (publ)	02-16	AQ
ProstaLund AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-16	CI
New agreement - Esbjerg Hospital starts up with CoreTherm® treatments	12-12	AQ
ProstaLund Signs an Agreement on Coretherm®? with the New Customer Sydvestjysk Sygehus	12-12	CI
Interim report - ProstaLund AB (publ)	11-07	AQ
ProstaLund AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-07	CI
Schelin Catheter® has had its premiere in France.	11/09/23	AQ
ProstaLund AB Announces its Schelin Catheter Premiere in France	11/09/23	CI
Schelin Catheter® beneficial together with TURP	05/09/23	AQ
ProstaLund signs sales agent agreement for France	31/08/23	AQ
Prostalund Signs Sales Agent Agreement for France	31/08/23	CI
Patent has been approved in China	15/08/23	AQ

No results for this search